Eosinophilic esophagitis
Upcoming SlideShare
Loading in...5
×
 
  • 403 views

Eosinophilic esophagitis

Eosinophilic esophagitis

Presented by Chuleeporn Kongmeesook, MD,

2013

Statistics

Views

Total Views
403
Views on SlideShare
403
Embed Views
0

Actions

Likes
0
Downloads
11
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Eosinophilic esophagitis Eosinophilic esophagitis Presentation Transcript

  • Eosinophilic Esophagitis CHULEEPORN KONGMEESOOK ,MD
  • Outline • Prevalence • Diagnosis • Clinical presentation • Endoscopic and Histologic finding • Management
  • Definition A chronic, immune/antigen-mediated esophageal disease characterized • Clinically by symptoms related to esophageal dysfunction • Histologically by eosinophil-predominant inflammation ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • • Non-Hispanic • White • Atopic males (male/female ratio 3:1) • Onset in childhood or during the third or fourth decades of life • Incidence 0.7-10 per 100,000 per person-year • Prevalence 0.2-43 per 100,000 Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Diagnosis • Symptomatic patients after a biopsy that confirms 15 Eos/HPF • At least one esophageal level (eg, distal, proximal) • In whom acid reflux has been ruled out Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Eosinophil associated esophagitis ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Clinical Manifestation Mirna Chehade et al Aceves Current Opinion in Allergy and Clinical Immunology 2010;10:231-237
  • • Any pt with symptoms suggestive of EoE should undergo careful history focus on eating and swallowing habits • Children and adults with EoE often rapidly adapt eating habits to manage their impaired esophageal function ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Endoscopic Finding • Esophageal endoscopy with biopsy  reliable diagnostic test for EoE • Appropriate clinical setting + any endoscopic finding supports but not establish the Dx of EoE • 2-4 mucosal specimens of the proximal and distal esophagus should be obtain ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Radiography • Not a recommended routinely • Helpful in selected cases anatomic abnormalities difficult to endoscope esophageal strictures (length and diameter) ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Histologic Finding 1 • At least 15 Eos/hpf in the maximally affected esophageal tissue • Histopathologic features of esophageal mucosal biopsy must be interpreted in with the patient’s clinical information ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Histologic Finding 2 • EoE might be focal and not be present in all biopsy specimens • Peak number of Eos/hpf as average number • Site and number of biopsy  Affect Eos count ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • • Esophageal pH monitoring (and pH impedance ) useful diagnostic test to evaluate for GERD in pts with esophageal eosinophilia • Peripheral eosinophil counts pts with EoE 40-50% having increased numbers of circulating Eos (>300-350 /mm3) • Total IgE inadequate data to support the utility of measuring total IgE level as a surrogate disease in pts with EoE ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Management Corticosteroid therapy • Increase eosinophil apoptosis • Downregulate eosinophil chemotaxis • Inhibit proinflammatory cytokines that promote eosinophil survival and activation Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Management Systemic oral corticosteroid • Induce remission of EoE symptoms and both gross and histologic features • Long-term steroid adverse effects and relapse after discontinuation Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Management Topical corticosteroid • Modulation of esophageal gene expression Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • ChrisA. Liacouras et al J Allergy Clin Immunol 2011;128:3-20
  • Management Dietary therapy • Elemental dietary therapy • Targeted dietary elimination • Empiric dietary elimination Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • Conclusions Matthew Greenhawat et al J Allergy Clin Immunol : In Practice 2013;1:332-40
  • THANK YOU